# Effect of Arginine on Microcirculation in Patients With Diabetes

> **NCT00902616** · PHASE4 · COMPLETED · sponsor: **Tameside Hospital NHS Foundation Trust** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** L-arginine
- **DIETARY_SUPPLEMENT:** Placebo Lactose powder

## Key facts

- **NCT ID:** NCT00902616
- **Lead sponsor:** Tameside Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902616, "Effect of Arginine on Microcirculation in Patients With Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00902616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*